Adverse Drug Reactions and Drug Safety

Monitoring adverse drug reactions (ADRs) is essential for ensuring drug safety. ADRs, ranging from mild effects to severe toxicity, can result from drug interactions, genetic factors, or dosage errors. Pharmacovigilance systems have evolved to track ADRs post-marketing, enabling early detection of risks. Personalized medicine, through pharmacogenomics, improves drug safety by predicting individual responses to therapies, minimizing ADRs, and optimizing treatment. Regulatory frameworks also play a crucial role in maintaining drug safety.

    Related Conference of Adverse Drug Reactions and Drug Safety

    November 20-21, 2024

    13th International Conference on Climate Change & Environmental Science

    Rome, Italy
    November 28-29, 2024

    19th World Convention on Waste Recycling and Reuse

    Paris, France
    December 18-19, 2024

    3rd International Conference and Expo on Medical Toxicology and Applied Pharmacology

    Zurich, Switzerland
    February 13-14, 2025

    4th World Congress on Endocrinology & Diabetes

    Rome, Italy
    February 24-25, 2025

    4th World Congress on Sustainable Waste Management

    Madrid, Spain
    March 10-11, 2025

    12th International Conference on Pollution Control & Sustainable Environment

    Rome, Italy
    April 14-15, 2025

    13th World Conference on Climate Change

    Aix-en-Provence, France
    April 14-15, 2025

    6th Global Summit on Environmental Health

    Amsterdam, Netherlands
    April 14-15, 2025

    4th World Congress on Climate change and Ecosystem

    Madrid, Spain
    June 16-17, 2025

    20th World Bioenergy Congress and Expo

    Frankfurt, Germany
    August 26-27, 2025

    13th International Conference on Green Energy

    Paris, France

    Adverse Drug Reactions and Drug Safety Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in